Works by Kawaratani, Hideto


Results: 108
    1
    2

    Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease.

    Published in:
    JGH Open, 2020, v. 4, n. 3, p. 400, doi. 10.1002/jgh3.12264
    By:
    • Tahara, Kazuki;
    • Akahane, Takemi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kawaratani, Hideto;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Kubo, Takuya;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Tsuji, Yuuki;
    • Kaya, Daisuke;
    • Ogawa, Hiroyuki
    Publication type:
    Article
    3

    Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.

    Published in:
    Oncology Letters, 2017, v. 14, n. 3, p. 3028, doi. 10.3892/ol.2017.6489
    By:
    • Akitoshi Douhara;
    • Tadashi Namisaki;
    • Kei Moriya;
    • Mitsuteru Kitade;
    • Kosuke Kaji;
    • Hideto Kawaratani;
    • Kosuke Takeda;
    • Yasushi Okura;
    • Hiroaki Takaya;
    • Ryuichi Noguchi;
    • Norihisa Nishimura;
    • Kenichiro Seki;
    • Shinya Sato;
    • Yasuhiko Sawada;
    • Junichi Yamao;
    • Akira Mitoro;
    • Masakazu Uejima;
    • Tsuyoshi Mashitani;
    • Naotaka Shimozato;
    • Soichiro Saikawa
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients.

    Published in:
    Antibiotics (2079-6382), 2020, v. 9, n. 4, p. 145, doi. 10.3390/antibiotics9040145
    By:
    • Kaji, Kosuke;
    • Saikawa, Soichiro;
    • Takaya, Hiroaki;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Kaya, Daisuke;
    • Tsuji, Yuki;
    • Sawada, Yasuhiko;
    • Kawaratani, Hideto;
    • Moriya, Kei;
    • Namisaki, Tadashi;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yoshiji, Hitoshi;
    • Leitão, Jorge H.
    Publication type:
    Article
    12
    13
    14
    15

    Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan.

    Published in:
    In Vivo, 2023, v. 37, n. 3, p. 1226, doi. 10.21873/invivo.13199
    By:
    • NOBUYUKI YORIOKA;
    • TADASHI NAMISAKI;
    • AKIHIKO SHIBAMOTO;
    • JUNYA SUZUKI;
    • TAKAHIRO KUBO;
    • SATOSHI IWAI;
    • FUMIMASA TOMOOKA;
    • MISAKO TANAKA;
    • SOICHI TAKEDA;
    • YUKI FUJIMOTO;
    • MASAHIDE ENOMOTO;
    • KOJI MUARATA;
    • TAKASHI INOUE;
    • YUKI TSUJI;
    • YUKIHISA FUJINAGA;
    • NORIHISA NISHIMURA;
    • KOH KITAGAWA;
    • HIROAKI TAKAYA;
    • KOSUKE KAJI;
    • HIDETO KAWARATANI
    Publication type:
    Article
    16

    Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy.

    Published in:
    In Vivo, 2022, v. 36, n. 3, p. 1477, doi. 10.21873/invivo.12854
    By:
    • TADASHI NAMISAKI;
    • YUKI TSUJI;
    • MITSUTERU KITADE;
    • NOBUYUKI YORIOKA;
    • YUKIHISA FUJINAGA;
    • YASUHIKO SAWADA;
    • NORIHISA NISHIMURA;
    • KOH KITAGAWA;
    • TAKASHI INOUE;
    • HIROAKI TAKAYA;
    • KOSUKE KAJI;
    • HIDETO KAWARATANI;
    • KEI MORIYA;
    • TAKEMI AKAHANE;
    • AKIRA MITORO;
    • HITOSHI YOSHIJI
    Publication type:
    Article
    17

    Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus‐related liver cirrhosis.

    Published in:
    Hepatology Research, 2024, v. 54, n. 12, p. 1116, doi. 10.1111/hepr.14077
    By:
    • Iwai, Satoshi;
    • Akahane, Takemi;
    • Takaya, Hiroaki;
    • Kubo, Takahiro;
    • Tomooka, Fumimasa;
    • Shibamoto, Akihiko;
    • Suzuki, Junya;
    • Tsuji, Yuki;
    • Fujinaga, Yukihisa;
    • Nishimura, Norihisa;
    • Kitagawa, Koh;
    • Kaji, Kosuke;
    • Kawaratani, Hideto;
    • Namisaki, Tadashi;
    • Matsumoto, Masanori;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    18
    19
    20

    Hemoglobin levels as a surrogate marker of sarcopenia in patients with liver cirrhosis.

    Published in:
    Hepatology Research, 2023, v. 53, n. 8, p. 713, doi. 10.1111/hepr.13904
    By:
    • Shibamoto, Akihiko;
    • Namisaki, Tadashi;
    • Suzuki, Junya;
    • Kubo, Takahiro;
    • Iwai, Satoshi;
    • Tomooka, Fumimasa;
    • Takeda, Soichi;
    • Fujimoto, Yuki;
    • Enomoto, Masahide;
    • Murata, Koji;
    • Inoue, Takashi;
    • Tsuji, Yuki;
    • Fujinaga, Yukihisa;
    • Nishimura, Norihisa;
    • Kitagawa, Koh;
    • Takaya, Hiroaki;
    • Kaji, Kosuke;
    • Kawaratani, Hideto;
    • Akahane, Takemi;
    • Mitoro, Akira
    Publication type:
    Article
    21

    Cell‐free and concentrated ascites reinfusion therapy versus large‐volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study.

    Published in:
    Hepatology Research, 2023, v. 53, n. 3, p. 238, doi. 10.1111/hepr.13860
    By:
    • Hanai, Tatsunori;
    • Kawaratani, Hideto;
    • Nagano, Junji;
    • Suii, Hirokazu;
    • Sakamaki, Akira;
    • Arase, Yoshitaka;
    • Nakanishi, Hiroyuki;
    • Kogiso, Tomomi;
    • Okubo, Tomomi;
    • Miwa, Takao;
    • Shimizu, Shogo;
    • Hige, Shuhei;
    • Atsukawa, Masanori;
    • Shimizu, Masahito;
    • Kurosaki, Masayuki;
    • Terai, Shuji;
    • Kagawa, Tatehiro;
    • Tokushige, Katsutoshi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    22

    Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute‐on‐chronic liver failure development and prognosis in patients with liver cirrhosis.

    Published in:
    Hepatology Research, 2022, v. 52, n. 4, p. 390, doi. 10.1111/hepr.13743
    By:
    • Enomoto, Masahide;
    • Takaya, Hiroaki;
    • Namisaki, Tadashi;
    • Fujinaga, Yukihisa;
    • Nishimura, Norihisa;
    • Sawada, Yasuhiko;
    • Kaji, Kosuke;
    • Kawaratani, Hideto;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Inoue, Takashi;
    • Matsumoto, Masanori;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    23
    24
    25
    26

    Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis.

    Published in:
    Hepatology Research, 2020, v. 50, n. 7, p. 840, doi. 10.1111/hepr.13509
    By:
    • Furukawa, Masanori;
    • Moriya, Kei;
    • Nakayama, Jiro;
    • Inoue, Takako;
    • Momoda, Rie;
    • Kawaratani, Hideto;
    • Namisaki, Tadashi;
    • Sato, Shinya;
    • Douhara, Akitoshi;
    • Kaji, Kosuke;
    • Kitade, Mitsuteru;
    • Shimozato, Naotaka;
    • Sawada, Yasuhiko;
    • Saikawa, Soichiro;
    • Takaya, Hiroaki;
    • Kitagawa, Koh;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    27

    Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1147, doi. 10.1111/hepr.13385
    By:
    • Shimozato, Naotaka;
    • Namisaki, Tadashi;
    • Kaji, Kosuke;
    • Kitade, Mitsuteru;
    • Okura, Yasushi;
    • Sato, Shinya;
    • Moriya, Kei;
    • Seki, Kenichiro;
    • Kawaratani, Hideto;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Fujinaga, Yukihisa;
    • Kubo, Takuya;
    • Asada, Kiyoshi;
    • Kitagawa, Koh;
    • Tsuji, Yuki;
    • Kaya, Daisuke
    Publication type:
    Article
    28

    Identification of clinical risk factors for histological progression of primary biliary cholangitis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 9, p. 1015, doi. 10.1111/hepr.13355
    By:
    • Fujinaga, Yukihisa;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Seki, Kenichiro;
    • Akahane, Takemi;
    • Okura, Yasushi;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Kubo, Takuya;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Tsuji, Yuki
    Publication type:
    Article
    29
    30

    Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 3, p. 284, doi. 10.1111/hepr.13281
    By:
    • Sawada, Yasuhiko;
    • Kawaratani, Hideto;
    • Kubo, Takuya;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Saikawa, Soichiro;
    • Sato, Shinya;
    • Seki, Kenichiro;
    • Takaya, Hiroaki;
    • Okura, Yasushi;
    • Kaji, Kosuke;
    • Shimozato, Naotaka;
    • Mashitani, Tsuyoshi;
    • Kitade, Mitsuteru;
    • Moriya, Kei;
    • Namisaki, Tadashi;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    31

    Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 2, p. 232, doi. 10.1111/hepr.13249
    By:
    • Okura, Yasushi;
    • Namisaki, Tadashi;
    • Sato, Shinya;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Seki, Kenichiro;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Fujinaga, Yukihisa;
    • Kubo, Takuya;
    • Kaya, Daisuke;
    • Tsuji, Yuki;
    • Ozutsumi, Takahiro
    Publication type:
    Article
    32
    33

    Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.

    Published in:
    Hepatology Research, 2017, v. 47, n. 12, p. 1317, doi. 10.1111/hepr.12860
    By:
    • Okura, Yasushi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kitade, Mitsuteru;
    • Takeda, Kosuke;
    • Kaji, Kosuke;
    • Noguchi, Ryuichi;
    • Nishimura, Norihisa;
    • Seki, Kenichiro;
    • Kawaratani, Hideto;
    • Takaya, Hiroaki;
    • Sato, Shinya;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Furukawa, Masanori;
    • Nakanishi, Keisuke;
    • Saikawa, Soichiro;
    • Kubo, Takuya;
    • Asada, Kiyoshi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    34

    Predictive parameter of tolvaptan effectiveness in cirrhotic ascites.

    Published in:
    Hepatology Research, 2017, v. 47, n. 9, p. 854, doi. 10.1111/hepr.12826
    By:
    • Kawaratani, Hideto;
    • Fukui, Hiroshi;
    • Moriya, Kei;
    • Noguchi, Ryuichi;
    • Namisaki, Tadashi;
    • Uejima, Masakazu;
    • Kitade, Mitsuteru;
    • Takeda, Kosuke;
    • Okura, Yasushi;
    • Kaji, Kosuke;
    • Nishimura, Norihisa;
    • Takaya, Hiroaki;
    • Aihara, Yousuke;
    • Sawada, Yasuhiko;
    • Sato, Shinya;
    • Seki, Kenichiro;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    35

    Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis.

    Published in:
    Hepatology Research, 2017, v. 47, n. 3, p. E178, doi. 10.1111/hepr.12746
    By:
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Noguchi, Ryuichi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Yamao, Junichi;
    • Mitoro, Akira;
    • Yoshida, Motoyuki;
    • Sawai, Masayoshi;
    • Uejima, Masakazu;
    • Mashitani, Tsuyoshi;
    • Takeda, Kosuke;
    • Okura, Yasushi;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Aihara, Yosuke;
    • Douhara, Akitoshi;
    • Nishimura, Norihisa;
    • Sawada, Yasuhiko;
    • Sato, Shinya
    Publication type:
    Article
    36

    Treatment for cirrhotic ascites.

    Published in:
    Hepatology Research, 2017, v. 47, n. 2, p. 166, doi. 10.1111/hepr.12769
    By:
    • Kawaratani, Hideto;
    • Fukui, Hiroshi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    37
    38

    ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score.

    Published in:
    Hepatology Research, 2012, v. 42, n. 5, p. 459, doi. 10.1111/j.1872-034X.2011.00950.x
    By:
    • Takaya, Hiroaki;
    • Uemura, Masahito;
    • Fujimura, Yoshihiro;
    • Matsumoto, Masanori;
    • Matsuyama, Tomomi;
    • Kato, Seiji;
    • Morioka, Chie;
    • Ishizashi, Hiromichi;
    • Hori, Yuji;
    • Fujimoto, Masao;
    • Tsujimoto, Tatsuhiro;
    • Kawaratani, Hideto;
    • Toyohara, Masahisa;
    • Kurumatani, Norio;
    • Fukui, Hiroshi
    Publication type:
    Article
    39
    40

    Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B.

    Published in:
    Experimental & Therapeutic Medicine, 2020, v. 20, n. 2, p. 985, doi. 10.3892/etm.2020.8798
    By:
    • Tsuji, Yuki;
    • Namisaki, Tadashi;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Nakanishi, Keisuke;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Sawada, Yasuhiko;
    • Kitagawa, Kou;
    • Shimozato, Naotaka;
    • Kawaratani, Hideto;
    • Moriya, Kei;
    • Noguchi, Ryuichi;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    41

    Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infection.

    Published in:
    Experimental & Therapeutic Medicine, 2018, v. 16, n. 3, p. 2743, doi. 10.3892/etm.2018.6481
    By:
    • Takeda, Kosuke;
    • Noguchi, Ryuichi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Seki, Kenichiro;
    • Fujinaga, Yukihisa;
    • Tsuji, Yuki;
    • Kubo, Takuya;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Kitagawa, Koh
    Publication type:
    Article
    42
    43
    44

    Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis.

    Published in:
    International Journal of Molecular Medicine, 2017, v. 40, n. 2, p. 263, doi. 10.3892/ijmm.2017.3015
    By:
    • HIDETO KAWARATANI;
    • KEI MORIYA;
    • TADASHI NAMISAKI;
    • MASAKAZU UEJIMA;
    • MITSUTERU KITADE;
    • KOUSUKE TAKEDA;
    • YASUSHI OKURA;
    • KOUSUKE KAJI;
    • HIROAKI TAKAYA;
    • NORIHISA NISHIMURA;
    • SHINYA SATO;
    • YASUHIKO SAWADA;
    • KENICHIRO SEKI;
    • TAKUYA KUBO;
    • AKIRA MITORO;
    • JUNICHI YAMAO;
    • HITOSHI YOSHIJI
    Publication type:
    Article
    45

    Gut Dysbiosis Associated With Hepatitis C Virus Infection.

    Published in:
    Clinical Infectious Diseases, 2018, v. 67, n. 6, p. 869, doi. 10.1093/cid/ciy205
    By:
    • Inoue, Takako;
    • Nakayama, Jiro;
    • Moriya, Kei;
    • Kawaratani, Hideto;
    • Momoda, Rie;
    • Ito, Kiyoaki;
    • Iio, Etsuko;
    • Nojiri, Shunsuke;
    • Fujiwara, Kei;
    • Yoneda, Masashi
    Publication type:
    Article
    46
    47
    48
    49
    50